John Larsen

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

High persistence of statin use in a Danish population: Compliance study 1993–1998

John Larsen, Morten Andersen, Jakob Kragstrup et al. · British Journal of Clinical Pharmacology · 2002 · 106 citations · Full text

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +13

Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: A population-based register study

Lise Bathum, René dePont Christensen, Lars Engers Pedersen et al. · Scandinavian Journal of Primary Health Care · 2013 · 70 citations · Full text

Medicine, Preventive Medicine, Clinical Epidemiology +16

Lack of adherence to lipid‐lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy

John Larsen, Alberto Vaccheri, Morten Andersen et al. · British Journal of Clinical Pharmacology · 2000 · 51 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Can differences in medical drug compliance between European countries be explained by social factors: analyses based on data from the European Social Survey, round 2

John Larsen, Henrik Støvring, Jakob Kragstrup et al. · BMC Public Health · 2009 · 42 citations · Full text

Pharmacy, Social Pharmacy, Health Care Compliance +12